Market Performance - The Hong Kong stock market experienced mixed results, with the Hang Seng Index rising by 0.13%, while the Hang Seng China Enterprises Index fell by 0.23%, and the Hang Seng Tech Index decreased by 0.75% [1] - Consumer sectors such as automotive dealers, sports goods, Hong Kong retail, luxury goods, and holiday concepts showed positive performance, with notable gains in stocks like Zhongsheng Holdings (00881.HK) up 4.8%, Anta Sports (02020.HK) up 1.86%, and Prada (01913.HK) up 4.41% [1] Monetary Policy Impact - The People's Bank of China announced a reduction in the reserve requirement ratio for automotive finance and financial leasing companies from 5% to 0%, alongside a 500 billion yuan initiative to support consumption and elderly care through low-cost funding [1] - A 0.5 percentage point cut in the reserve requirement ratio was also announced, providing approximately 1 trillion yuan in long-term liquidity to the market, which is expected to improve market liquidity and boost investor confidence [1] Sector Performance - Coal stocks saw significant gains, with Nanshan Resources (01229.HK) rising by 13.46% and China Shenhua (01088.HK) increasing by 1.53% [2] - Port transportation stocks performed well, with Pacific Basin Shipping (02343.HK) up 3.49% and Orient Overseas International (00316.HK) up 1.53% [2] - Oil and gas stocks were active, with China Petroleum (00857.HK) rising by 2.2% and China National Offshore Oil (00883.HK) also seeing gains [2] Declining Sectors - Pharmaceutical stocks continued to decline, with notable drops in BeiGene (06160.HK) down 7.96% and WuXi Biologics (02269.HK) down 6.67% [3] - Robotics and chip sectors also faced declines, with companies like AAC Technologies (01415.HK) down 5.98% and Xiaomi Group (01810.HK) down 2.81% [3] - Other sectors such as cosmetics, tobacco, dairy, and food also saw weakness, with Mengniu Dairy (02319.HK) down 3.6% and Vitasoy International (00345.HK) down 2.85% [3]

恒生指数收盘涨0.13%，恒生科技指数跌0.75%。医药股跌幅居前，百济神州跌近8%，药明生物跌近 7%，药明康德跌近3%。南向资金净卖出78.66亿元。 ...

金十数据5月7日讯，港股今日高开低走，反覆向下。恒指高开507点报23169点，开市已重上50天线，升 幅曾扩大至534点高见23197点，创4月2日后一个月高位，但随后买盘未有跟进，大市升幅震荡收窄。午 后一度回顺，但尾盘抛压加重，涨幅再度回吐。截至收盘，恒指收涨0.13%；科指收跌0.75%，恒指大 市成交额2400.5亿元。盘面上，内房、服装、影视娱乐股走强，纸业、体育用品股回暖，军工股强势领 涨；生物医药、电讯设备、玩具消闲股走低，公共运输、非酒精饮料、医药外包概念股回调，汽车股再 度走弱。个股方面，领展房地产基金(00823.HK)涨超6.6%，中升控股(00881.HK)涨近5%，友邦保险 (01299.HK)涨近3%，理想汽车(02015.HK)、携程集团(09961.HK)、中国石油股份(00857.HK)均涨超 2%；药明生物(02269.HK)跌超6.6%，蒙牛乳业(02319.HK)、中国生物制药(01177.HK)均跌超3%，小米 集团(01810.HK)跌近3%。 港股收评：恒指收涨0.13% 大市受制于50日线 ...

Group 1 - The Hang Seng Index closed up by 0.13%, while the Tech Index fell by 0.75% [1] - Zhongsheng Holdings (00881.HK) rose nearly 5%, and AIA Group (01299.HK) increased by almost 3% [1] - WuXi Biologics (02269.HK) dropped nearly 6.7%, while Mengniu Dairy (02319.HK) and China National Pharmaceutical Group (01177.HK) both fell over 3% [1]

智通财经5月7日电，香港恒生指数收涨0.13%，恒生科技指数跌0.75%。博雷顿上市首日涨超38%，弘业 期货涨超34%；百济神州跌超7%，药明生物跌超6%，泡泡玛特跌超5%。 香港恒生指数收涨0.13% 恒生科技指数跌0.75% ...

- Model Name: Hong Kong Stock Selection 20 Portfolio; Model Construction Idea: The portfolio is constructed by selecting the top 20 stocks with the highest scores at the end of each month and equally weighting them; Detailed Construction Process: The model uses four types of factors (technical, capital, fundamental, and analyst expectations) to score Hong Kong Stock Connect constituent stocks. The top 20 stocks are selected based on these scores and equally weighted to form the portfolio. The benchmark is the Hong Kong Composite Index (HKD) (930930.CSI) [4][39]; Model Evaluation: The model has shown superior performance in the Hong Kong Stock Connect constituent stocks [4][37] - Factor Name: Technical Factor; Factor Construction Idea: The factor is constructed based on technical indicators; Detailed Construction Process: The specific technical indicators used and their calculation methods are not detailed in the report [4][37] - Factor Name: Capital Factor; Factor Construction Idea: The factor is constructed based on capital flow data; Detailed Construction Process: The specific capital flow data used and their calculation methods are not detailed in the report [4][37] - Factor Name: Fundamental Factor; Factor Construction Idea: The factor is constructed based on fundamental financial data; Detailed Construction Process: The specific fundamental financial data used and their calculation methods are not detailed in the report [4][37] - Factor Name: Analyst Expectations Factor; Factor Construction Idea: The factor is constructed based on analyst expectations; Detailed Construction Process: The specific analyst expectations data used and their calculation methods are not detailed in the report [4][37] Model Backtest Results - Hong Kong Stock Selection 20 Portfolio, Annualized Excess Return: 13.7%, Excess Return Volatility Ratio: 1.0 [4][40][41] Factor Backtest Results - Technical Factor, specific backtest results not detailed in the report - Capital Factor, specific backtest results not detailed in the report - Fundamental Factor, specific backtest results not detailed in the report - Analyst Expectations Factor, specific backtest results not detailed in the report

Market Performance - As of May 7, 2025, the Hang Seng Healthcare Index (HSHCI) decreased by 3.02%, with mixed performance among constituent stocks [3] - Leading gainers included Yuan Da Pharmaceutical (00512) up 12.52%, Shanghai Pharmaceuticals (02607) up 2.23%, and China Traditional Chinese Medicine (00570) up 1.96% [3] - Major decliners were Sangfor Technologies (01530) down 8.40%, Ascentage Pharma-B (06855) down 8.13%, and BeiGene (06160) down 7.70% [3] - The Hang Seng Healthcare ETF (513060) fell by 2.65%, closing at 0.48 yuan, with an active trading volume of 1.096 billion yuan [3] Investment Insights - Dongfang Securities noted that the continuous release of diagnostic and treatment demand, along with the commercialization of domestic innovative products, is leading to marginal improvements in certain sectors [3] - The firm believes that the upcoming quarters will see confirmed industry growth due to supply-side innovations driving rapid demand growth, suggesting that now is an excellent time to allocate resources to the healthcare sector [3] Future Investment Trends - Guolian Minsheng Securities anticipates that overseas expansion of innovative drugs, AI integration, and left-side asset valuation recovery will be key investment themes in the pharmaceutical sector for 2025 [4] - Recommendations include traditional pharmaceutical companies with manageable risks and reasonable valuations, as well as innovative drug companies with strong R&D foundations and competitive products for overseas markets [4] ETF Performance Metrics - As of May 6, 2025, the Hang Seng Healthcare ETF has seen a 28.71% increase in net value over the past year [5] - The ETF's highest monthly return since inception was 28.34%, with an average monthly return of 6.79% [5] - The ETF's management fee is 0.50%, and the tracking error is 0.041%, indicating high tracking precision compared to similar funds [5] Top Holdings - The top ten weighted stocks in the Hang Seng Healthcare Index account for 57.17% of the index, with major players including BeiGene (06160) and WuXi Biologics (02269) [6][8]

金融、地产赛道走强！ 今天上午A股市场整体走高，其中金融、房地产板块走强，领涨市场。 港股市场方面，在港上市的内地金融股普遍大幅上涨。港股通标的中，弘业期货港股盘中大涨逾70%。 A股市场盘中上行金融和房地产板块走强 今天上午A股市场整体走高。 受到利好消息提振，上午金融板块涨幅居前，银行板块中，四大行盘中悉数上行，西安银行盘中涨幅超过3%。非银金融板块中，弘业期货A股、九鼎投 资、锦龙股份等盘中触及涨停。互联网券商龙头东方财富盘中涨幅一度超过7%，后涨幅收窄。 房地产板块亦表现强势，三湘印象、天保基建涨停，另有多股盘中涨幅超过5%。 消息面上，央行今日发布多则公告。 为实施好适度宽松的货币政策，加力支持实体经济，从2025年5月8日起，公开市场7天期逆回购操作利率由此前的1.50%调整为1.40%。公开市场14天期逆 回购和临时正、逆回购的操作利率继续在公开市场7天期逆回购操作利率上加减点确定，加减点幅度保持不变。 为落实中央经济工作会议精神和《政府工作报告》部署，实施适度宽松的货币政策，提高宏观调控的前瞻性、针对性、有效性，中国人民银行决定，自 2025年5月15日起，下调金融机构存款准备金率0.5个百分 ...

Market Overview - The Hang Seng Index (HSI) closed up 0.49% after opening significantly higher, gaining 507 points to reach 23,169 points, and later peaking at 23,197 points, the highest level since April 2 [1] - The total market turnover was 1,480 million HKD, indicating active trading [1] Sector Performance - Strong performance was noted in the military industry stocks, which led the market gains [1] - Other sectors that performed well included automotive dealers, heavy machinery, and apparel stocks [1] - Conversely, sectors such as biomedicine, telecommunications equipment, and leisure toys saw declines, with public transport, non-alcoholic beverages, and pharmaceutical outsourcing concepts also experiencing pullbacks [1] Notable Stocks - Individual stock movements included a 6% increase in Zhongsheng Holdings (00881.HK), over 4% rise in Tencent Music (01698.HK), nearly 3% gain in Trip.com Group (09961.HK), and over 2% increase in BYD Electronics (00285.HK) [1] - On the downside, WuXi Biologics (02269.HK) and Horizon Robotics (09660.HK) both fell over 5%, while WuXi AppTec (02359.HK) dropped nearly 3.5%, and Xiaomi Group (01810.HK) decreased by 2.6% [1]

Group 1 - The Hong Kong stock market continues to attract capital inflows due to its high dividends and the scarcity of new economy assets, with a net inflow of 605.25 billion HKD as of May 5 [1] - Invesco Great Wall Fund has developed a comprehensive product matrix of Hong Kong stock ETFs covering key sectors such as technology, consumption, pharmaceuticals, and dividends, catering to diverse investor needs [1] - The performance of various Hong Kong stock indices shows significant growth, with the Hong Kong Stock Connect Technology Index rising by 26.56% in the past six months and 52.75% over the past year [1] Group 2 - The Hong Kong Technology 50 ETF (513980) has seen a substantial increase in shares, with a total of 21.4 billion shares and a scale of 15 billion RMB, ranking first among similar index ETFs [2] - The Hang Seng Consumption ETF (513970) focuses on a wide range of consumer sectors, reflecting the transformation of the Chinese economy and the rise of young consumers [2] - The Hong Kong Innovative Drug 50 ETF (513780) covers leading companies in the innovative drug sector, benefiting from government policies supporting innovation in pharmaceuticals [2] Group 3 - In addition to high-growth sectors, Invesco Great Wall Fund has also positioned itself in high-dividend assets through the Hong Kong Dividend Low Volatility ETF (159569) and the Hong Kong Central Enterprise Dividend 50 ETF (520990) [2] - The product matrix of Hong Kong stock ETFs provides investors with diverse and convenient investment tools, enhancing the overall investment landscape in the Hong Kong market [2] - The outlook for the market suggests that changes in overseas capital attitudes towards Chinese assets and the confidence of A-share investors may lead to an overall uplift in the Hong Kong stock market [2]